Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$2.74 - $6.87 $169,003 - $423,741
61,680 New
61,680 $423,000
Q2 2022

Aug 15, 2022

SELL
$2.09 - $3.71 $121,163 - $215,079
-57,973 Reduced 48.3%
62,062 $199,000
Q1 2022

May 11, 2022

BUY
$2.84 - $4.52 $488 - $777
172 Added 0.14%
120,035 $363,000
Q4 2021

Feb 11, 2022

BUY
$3.87 - $6.59 $5,286 - $9,001
1,366 Added 1.15%
119,863 $534,000
Q3 2021

Nov 12, 2021

BUY
$6.22 - $15.54 $68,208 - $170,411
10,966 Added 10.2%
118,497 $777,000
Q2 2021

Aug 11, 2021

BUY
$10.15 - $17.25 $422,889 - $718,704
41,664 Added 63.25%
107,531 $1.72 Million
Q1 2021

May 13, 2021

SELL
$10.6 - $21.27 $110,314 - $221,356
-10,407 Reduced 13.64%
65,867 $814,000
Q4 2020

Feb 09, 2021

BUY
$4.95 - $11.45 $47,049 - $108,832
9,505 Added 14.24%
76,274 $847,000
Q2 2020

Aug 12, 2020

BUY
$1.41 - $2.61 $27,118 - $50,198
19,233 Added 40.46%
66,769 $128,000
Q1 2020

May 06, 2020

BUY
$1.28 - $4.5 $21,231 - $74,641
16,587 Added 53.59%
47,536 $89,000
Q4 2019

Feb 14, 2020

BUY
$4.03 - $9.22 $3,143 - $7,191
780 Added 2.59%
30,949 $138,000
Q3 2019

Nov 07, 2019

SELL
$8.31 - $13.03 $11,110 - $17,421
-1,337 Reduced 4.24%
30,169 $250,000
Q2 2019

Aug 12, 2019

BUY
$9.0 - $17.2 $11,430 - $21,844
1,270 Added 4.2%
31,506 $394,000
Q1 2019

May 14, 2019

BUY
$13.6 - $19.58 $151,776 - $218,512
11,160 Added 58.5%
30,236 $461,000
Q4 2018

Feb 11, 2019

BUY
$16.0 - $31.84 $71,328 - $141,942
4,458 Added 30.5%
19,076 $370,000
Q3 2018

Nov 09, 2018

BUY
$24.32 - $37.54 $355,509 - $548,759
14,618 New
14,618 $0

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $37.6M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Bank Of New York Mellon Corp Portfolio

Follow Bank Of New York Mellon Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.